| ICON provides outsourced development and commercialization services to pharmaceutical, biotechnology, medical device, and government and public health organizations. Co. provides a range of clinical, consulting and commercial services ranging from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization. Co. provides its services across a range of clinical outsourcing operating models including strategic partnerships, preferred provider, full-service delivery to functional service provision and stand-alone services. Co. focuses on development, management and analysis of programs that support clinical development process. We show 11 historical shares outstanding datapoints in our ICLR shares outstanding history coverage, used to compute ICLR market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ICLR market cap history over the course of time is important for investors
interested in comparing ICLR's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ICLR versus a peer is one thing; comparing
ICLR market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ICLR can fluctuate over the course of history.
With this page we aim to empower investors researching ICLR by allowing them to research the ICLR market cap history.